Business Of Biotech Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
6 snips
May 27, 2024 Dr. Brian Fiske of Mythic Therapeutics shares his journey transitioning from academia to biotech industry. They discuss developing ADCs for lung cancer, challenges in funding, and strategic planning. The podcast explores Mythic's unique approach in the ADC space and navigating the competitive biotech industry.
AI Snips
Chapters
Transcript
Episode notes
Joining Flagship Pioneering
- Fisk joined Flagship Pioneering to understand what makes a successful biotech company.
- He wanted to learn from observing multiple biotech creations simultaneously.
Evaluating Bad Ideas
- Early-stage entrepreneurs should take bad ideas seriously and analyze why they are not popular.
- Evaluate how you can change that and build a company around it.
Mythic's Focus on Antibodies
- Mythic Therapeutics focuses on improving the antibody component of ADCs.
- They aim to enhance payload delivery to cancer cells and reduce delivery to healthy cells.